디엑스앤브이엑스(주)

{
  "address": "서울특별시 금천구",
  "ceo_name": "이용구, 권규찬",
  "certificate": [
    {
      "cert_number": "20080400082",
      "changes": "",
      "disclosure_date": "2008-02-28",
      "first_cert_date": "2008-02-28",
      "no": "1",
      "type": "연구개발유형",
      "valid_period": "2008-02-28 ~ 2010-02-27"
    },
    {
      "cert_number": "20100400223",
      "changes": "",
      "disclosure_date": "2010-04-12",
      "first_cert_date": "2008-02-28",
      "no": "2",
      "type": "연구개발유형",
      "valid_period": "2010-02-28 ~ 2012-02-27"
    },
    {
      "cert_number": "20120400263",
      "changes": "",
      "disclosure_date": "2012-05-02",
      "first_cert_date": "2008-02-28",
      "no": "3",
      "type": "연구개발유형",
      "valid_period": "2012-02-28 ~ 2014-02-27"
    },
    {
      "cert_number": "20140300066",
      "changes": "",
      "disclosure_date": "2014-03-13",
      "first_cert_date": "2008-02-28",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2014-02-28 ~ 2016-02-27"
    },
    {
      "cert_number": "20160300011",
      "changes": "",
      "disclosure_date": "2016-01-13",
      "first_cert_date": "2008-02-28",
      "no": "5",
      "type": "벤처투자유형",
      "valid_period": "2016-02-28 ~ 2018-02-27"
    },
    {
      "cert_number": "20180400320",
      "changes": "",
      "disclosure_date": "2018-02-28",
      "first_cert_date": "2008-02-28",
      "no": "6",
      "type": "연구개발유형",
      "valid_period": "2018-02-28 ~ 2020-02-27"
    },
    {
      "cert_number": "20200400458",
      "changes": "",
      "disclosure_date": "2020-03-16",
      "first_cert_date": "2008-02-28",
      "no": "7",
      "type": "연구개발유형",
      "valid_period": "2020-02-28 ~ 2022-02-27"
    },
    {
      "cert_number": "20220622020053",
      "changes": "",
      "disclosure_date": "2022-06-22",
      "first_cert_date": "2008-02-28",
      "no": "8",
      "type": "연구개발유형",
      "valid_period": "2022-06-22 ~ 2025-06-21"
    },
    {
      "cert_number": "20250709020028",
      "changes": "",
      "disclosure_date": "2025-07-09",
      "first_cert_date": "2008-02-28",
      "no": "9",
      "type": "연구개발유형",
      "valid_period": "2025-06-22 ~ 2028-06-21"
    }
  ],
  "company_name": "디엑스앤브이엑스(주)",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 14346443000,
      "cost_of_sales": 19457176000,
      "current_assets": 32361259000,
      "current_liabilities": 26334615000,
      "gross_profit": 9136064000,
      "net_income": -2128206000,
      "net_income_bs": -895287000,
      "non_current_assets": 41306756000,
      "non_current_liabilities": 13194022000,
      "non_operating_expenses": 5895483000,
      "non_operating_income": 1707464000,
      "operating_profit": 2059813000,
      "revenue": 28593240000,
      "sga_expenses": 7076250000,
      "total_assets": 73668015000,
      "total_equity": 34139377000,
      "total_liabilities": 39528637000
    },
    "2023": {
      "capital_stock": 15109716000,
      "cost_of_sales": 15945650000,
      "current_assets": 17485401000,
      "current_liabilities": 50335050000,
      "gross_profit": 3067044000,
      "net_income": -27674320000,
      "net_income_bs": -27086897000,
      "non_current_assets": 55417195000,
      "non_current_liabilities": 833391000,
      "non_operating_expenses": 15931995000,
      "non_operating_income": 3464167000,
      "operating_profit": -15206492000,
      "revenue": 19012694000,
      "sga_expenses": 18273536000,
      "total_assets": 72902596000,
      "total_equity": 21734154000,
      "total_liabilities": 51168442000
    },
    "2024": {
      "capital_stock": 24609716000,
      "cost_of_sales": 18286151000,
      "current_assets": 18504052000,
      "current_liabilities": 11794781000,
      "gross_profit": 647390000,
      "net_income": -48740055000,
      "net_income_bs": -48604768000,
      "non_current_assets": 35196241000,
      "non_current_liabilities": 28945269000,
      "non_operating_expenses": 30852136000,
      "non_operating_income": 1181070000,
      "operating_profit": -19068989000,
      "revenue": 18933542000,
      "sga_expenses": 19716379000,
      "total_assets": 53700292000,
      "total_equity": 12960242000,
      "total_liabilities": 40740051000
    }
  },
  "industry": "물질성분 검사 및 분석업",
  "investment": [
    {
      "amount": "3,730,398,000",
      "changes": "3,730,398,000",
      "date": "2012-12-10"
    }
  ],
  "main_products": "유전체분석 및 연구개발,진단검사서비스,유전자발현/기전연구 및 기능 분석(NGS,SNP칩,BAC칩),다중오믹스 분석/개인맞춤 백신개발,분자진단키트 제품 개발",
  "phone": "02-890-****",
  "years": [
    2024,
    2023,
    2022
  ]
}